METHOD OF PEGET BREAST CANCER TREATMENT Russian patent published in 2008 - IPC A61K35/14 A61K31/675 A61K31/704 A61K31/505 A61P35/00 A61B17/00 A61M1/36 

FIELD: medicine; carcinology.

SUBSTANCE: can be applied for treatment of Peget breast cancer. Method substance implies that autoblood is sampled from peripheral vein in two bottles with hemo-preserving agent, 100 ml in each bottle. First bottle is added with doxorubicin dosed 50 mg/m, and second one is added with 5-fluorouracil dosed 750 mg/m² , after that both bottles are incubated in thermostat at temperature 37°C during 30 minutes. Content of first bottle is injected with intravenous dropper followed by the second bottle content on the first and the eighth day of treatment course. Additionally from the first to the seventh day of treatment course cyclophosphan dosed 200 mg/m² is injected intramuscularly. Then in 2 weeks after the last injection of chemical agents surgical procedure is performed in radical volume.

EFFECT: reduced tumour mass, provided epithelisation of skin ulcer, prevented by-effect toxicity of chemotherapy and metastases.

2 dwg, 1 ex